Overview
What is Dayton Clinical Oncology Program Inc?
Dayton Clinical Oncology Program Inc, established in 1983, is a distinguished nonprofit organization located in Dayton, Ohio. With a mission to provide access to cutting-edge National Cancer Institute (NCI) clinical trials, it serves communities across Ohio and Eastern Indiana. As a member of the NCI network, it offers trial options for both newly diagnosed and advanced cancer patients, encompassing treatment, symptom management, cancer care delivery, and demographic studies. The collaboration between Dayton Clinical Oncology Program and its consortium members, consisting of seven hospitals, 60 physicians, and hospital-based oncology research coordinators, is instrumental in its success and accessibility for cancer patients. The organization's overarching objective is to minimize cancer incidence and mortality within the local community through improved treatment and prevention methods. With a dedicated workforce of 16 individuals, Dayton Clinical Oncology Program Inc is committed to making advanced cancer research widely available in the region.
Official website here: www.daytonncorp.org
What are the reviews and ratings of this charity?
Charity Navigator Rating: 96%, Four-Star out of Four Stars
The Dayton Clinical Oncology Program Inc has achieved a remarkable Four-Star rating from Charity Navigator, reflecting its strong commitment to accountability and financial practices. The organization has an impressive score of 96% in the Accountability & Finance category, demonstrating effective oversight and governance. Notably, the board comprises entirely independent members, ensuring impartiality in decision-making.
Strengths highlighted in the evaluation include a strong financial management structure with a high program expense ratio of 90%, indicating that a significant portion of its resources are dedicated to its mission. The nonprofit also adheres to best practices by having policies in place for conflict of interest, whistleblowing, and document retention, which contributes to its overall transparency and integrity.
While the organization shows no signs of financial distress, as indicated by a low liabilities to assets ratio of 17.64%, there are no specific weaknesses noted in the data. Overall, Dayton Clinical Oncology Program Inc stands out as a financially responsible and well-governed nonprofit focused on delivering impactful services.
This AI summary has been generated from information found on Charity Navigator.
Is Dayton Clinical Oncology Program Inc legitimate?
Dayton Clinical Oncology Program Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Dayton Clinical Oncology Program Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $120,261
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.daytonncorp.org
What is the mission statement of Dayton Clinical Oncology Program Inc?
The Dayton Clinical Oncology Program Inc, established in 1983, is committed to reducing cancer incidence and mortality within local communities. It achieves this mission by offering national, state-of-the-art cancer research, including clinical trials, to local populations. As a member of the National Cancer Institute (NCI) network, the program provides access to phase II and phase III trials for both newly diagnosed and advanced cancer patients. The collaboration between Dayton Clinical Oncology Program and its consortium members, including hospitals, medical, surgical, and radiation oncologists, and hospital-based oncology research coordinators, ensures the program's success and availability for cancer patients, offering treatment, symptom management, cancer care delivery, and demographic trials options.
Official website here: www.daytonncorp.org
Who is the CEO of Dayton Clinical Oncology Program Inc?
Michelle Kinney is the Chairperson of Dayton Clinical Oncology Program Inc. The CEO's salary of Dayton Clinical Oncology Program Inc is $95,261 and their total compensation is $107,974.
Official website here: www.daytonncorp.org
What is the revenue of Dayton Clinical Oncology Program Inc?
Dayton Clinical Oncology Program Inc's revenue in 2022 was $1,120,839.
Official website here: www.daytonncorp.org
Who are the executives of Dayton Clinical Oncology Program Inc and what are their salaries?
The average compensation at Dayton Clinical Oncology Program Inc during 2022 was $7,516. There are 16 employees at Dayton Clinical Oncology Program Inc.
Here are 12 key members and their salaries (Dayton Clinical Oncology Program Inc's CEO's salary is $95,261 and their total compensation is $107,974):
- Compensation: $25,000
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $95,261
- Related: $0
- Other: $12,713
Official website here: www.daytonncorp.org
Where can I find the form 990 for Dayton Clinical Oncology Program Inc?
Dayton Clinical Oncology Program Inc's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.daytonncorp.org
Learn more at the official website: www.daytonncorp.org
Mission Statement of Dayton Clinical Oncology Program Inc
Dayton Clinical Oncology Program, established in 1983, is committed to reducing cancer incidence and mortality within its local community. Its mission is achieved by offering national, state-of-the-art cancer research to local communities. This renowned organization, designated as one of the original National Cancer Institute (NCI) grant-funded Community Clinical Oncology Programs, aims to provide access to a wide range of clinical trials, including phase II and phase III trials, for both newly diagnosed and advanced cancer patients. This access to cutting-edge treatments, symptom management, and cancer care delivery is made possible through its collaboration with several hospitals, over 60 physicians, and hospital-based oncology research coordinators. The program's success is largely attributed to this extensive network, which ensures that cancer patients in the community have access to the most advanced treatments available.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Dayton Clinical Oncology Program Inc plays a critical role in the fight against cancer within the local community by significantly reducing cancer incidence and mortality rates. Established in 1983, this program stands out as one of the pioneering National Cancer Institute (NCI) grant-funded community clinical oncology programs, providing essential access to state-of-the-art clinical trials.
The program facilitates participation in Phase II and III trials, which are crucial for newly diagnosed and advanced cancer patients. These trials not only offer innovative treatment options but also enhance symptom management and the overall delivery of cancer care. By being part of the NCI network, the Dayton Clinical Oncology Program ensures that patients in Ohio and eastern Indiana have access to cutting-edge research and treatments that are typically only available at major cancer centers.
Collaboration is a cornerstone of the program's success, involving partnerships with seven hospitals and a network of 60 physicians specializing in medical, surgical, and radiation oncology. The extensive experience and expertise of hospital-based oncology research coordinators further enrich the program, enabling it to meet the diverse needs of cancer patients effectively.
In summary, the Dayton Clinical Oncology Program Inc directly impacts the health and well-being of the community by improving cancer treatment and prevention strategies through innovative research, ultimately working to save lives and improve the quality of care for those affected by cancer.
This information is meant to be a general summary of Dayton Clinical Oncology Program Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $40,857
- Program Service Revenue: $163,147
- Gross Receipts: $1,120,839
Assets and Liabilities:
- Total Assets: $2,853,577
- Total Liabilities: $44,565
- Net Assets: $2,809,012
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CANCER STUDIES
Revenue
$130,147
MEMBERSHIPS
Revenue
$33,000
Organization Details
Founding Year
1983
Phone
(937) 528-2900Principal Officer
Michelle Kinney
Main Address
6480 CENTERVILLE BUSINESS PKWY, DAYTON, OH, 45459
Website
www.daytonncorp.orgNTEE Category
Code: G30Z - Disease
If you are a representative of Dayton Clinical Oncology Program Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.